Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral doxycycline to prevent recurrence of multiple endometrial polyps after hysteroscopic resection
ChiCTR2200061961Phase 4Not yet recruiting
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in endometrial polyp and endometritis comparing Experimental group - doxycycline with Control group - placebo (2 arms). Primary endpoints: Recurrence rate of endometrial polyps, Miscarriage rate and 2 more. Planned start Jul 2022; status: not yet recruiting.
02
Drugs
doxycycline
03
Conditions
endometrial polypendometritis
Beyond the preview
Go deeper on ChiCTR2200061961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061961.